Trial Profile

Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 26 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dapagliflozin (Primary)
Indications Type 1 diabetes mellitus
Focus Therapeutic Use
Acronyms ATTEMPT

Most Recent Events

24 Jun 2024 According to a American Diabetes Association media release, the ATTEMPT Study was supported by JDRF Canada in partnership with the Canadian Institute of Health Research (CIHR), Strategies for Patient Oriented Research (SPOR).
24 Jun 2024 According to an American Diabetes Association media release, results were presented as a Late-Breaking Symposium at the 84th Scientific Sessions of the American Diabetes Association (ADA) in Orlando, FL.
24 Jun 2024 Results presented in the diabetis.org Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com